Top ▲
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 2458 | 12q24.11 | ACACB | acetyl-CoA carboxylase beta | |
Mouse | - | - | Acacb | acetyl-Coenzyme A carboxylase beta | ||
Rat | - | - | Acacb | acetyl-CoA carboxylase beta |
Previous and Unofficial Names ![]() |
ACACB | ACCβ | ACCB | acetyl-Coenzyme A carboxylase beta | acetyl-CoA carboxylase beta | acetyl-Coenzyme A carboxylase 2 |
Database Links ![]() |
|
Alphafold | O00763 (Hs) |
BRENDA | 6.4.1.2 |
CATH/Gene3D | 3.30.1490.20 |
ChEMBL Target | CHEMBL4829 (Hs) |
Ensembl Gene | ENSG00000076555 (Hs), ENSMUSG00000042010 (Mm), ENSRNOG00000000658 (Rn) |
Entrez Gene | 32 (Hs), 100705 (Mm), 116719 (Rn) |
Human Protein Atlas | ENSG00000076555 (Hs) |
KEGG Enzyme | 6.4.1.2 |
KEGG Gene | hsa:32 (Hs), mmu:100705 (Mm), rno:116719 (Rn) |
OMIM | 601557 (Hs) |
Pharos | O00763 (Hs) |
UniProtKB | O00763 (Hs) |
Wikipedia | ACACB (Hs) |
Enzyme Reaction ![]() |
||||
|
Products ![]() |
||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Allosteric Modulators | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
1. Griffith DA, Dow RL, Huard K, Edmonds DJ, Bagley SW, Polivkova J, Zeng D, Garcia-Irizarry CN, Southers JA, Esler W et al.. (2013) Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure. J Med Chem, 56 (17): 7110-9. [PMID:23981033]
2. Harriman G, Greenwood J, Bhat S, Huang X, Wang R, Paul D, Tong L, Saha AK, Westlin WF, Kapeller R et al.. (2016) Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. Proc Natl Acad Sci USA, 113 (13): E1796-805. [PMID:26976583]
3. Takagi H, Tanimoto K, Shimazaki A, Tonomura Y, Momosaki S, Sakamoto S, Abe K, Notoya M, Yukioka H. (2020) A Novel Acetyl-CoA Carboxylase 2 Selective Inhibitor Improves Whole-Body Insulin Resistance and Hyperglycemia in Diabetic Mice through Target-Dependent Pathways. J Pharmacol Exp Ther, 372 (3): 256-263. [PMID:31900320]
4. Waring JF, Yang Y, Healan-Greenberg CH, Adler AL, Dickinson R, McNally T, Wang X, Weitzberg M, Xu X, Lisowski A et al.. (2008) Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway. J Pharmacol Exp Ther, 324 (2): 507-16. [PMID:18025247]
5. Zhou W, Simpson PJ, McFadden JM, Townsend CA, Medghalchi SM, Vadlamudi A, Pinn ML, Ronnett GV, Kuhajda FP. (2003) Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res, 63 (21): 7330-7. [PMID:14612531]
Carboxylases: Acetyl-CoA carboxylase 2. Last modified on 14/02/2020. Accessed on 20/05/2022. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1264.